SmartCells
Insulin and polymer-based products for the treatment of diabetes, fertility, thyroid, and growth hormone deficiencies.
Launch date
Employees
Market cap
-
Enterprise valuation
€455m (Public information from Dec 2010)
Beverly Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | Grant | |
N/A | Angel | ||
$500k | Series A | ||
$1.0m | Series A | ||
N/A | Grant | ||
N/A | Series B | ||
$390k | Grant | ||
$280k | Grant | ||
N/A | Series C | ||
$1.5m | Grant | ||
$4.1m | Series D | ||
N/A | $1.1m | Debt | |
$4.1m | Series D | ||
$500m Valuation: $500m | Acquisition | ||
Total Funding | €10.8m |